within Pharmacolibrary.Drugs.ATC.V;

model V03AG05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.0015,
    adminDuration  = 600,
    adminMass      = 45 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V03AG05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sodium phosphate is an inorganic phosphate salt used primarily as a saline laxative for bowel cleansing prior to colonoscopy or other procedures. It is also used to treat hypophosphatemia and as an electrolyte replacement in certain conditions. While it was widely used, some oral formulations were withdrawn or restricted in several countries due to risk of acute phosphate nephropathy. Intravenous or rectal forms are still used clinically.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters in healthy adults, as no direct clinical studies reporting compartmental parameters for sodium phosphate could be identified.</p><h4>References</h4><ol><li><p>Thomas, L, et al., &amp; Rieg, T (2019). Contribution of NHE3 and dietary phosphate to lithium pharmacokinetics. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 128 1–7. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2018.11.008&quot;>10.1016/j.ejps.2018.11.008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30419292/&quot;>https://pubmed.ncbi.nlm.nih.gov/30419292</a></p></li><li><p>Wang, X, et al., &amp; Wetterau, JR (2022). Effects of pharmacological inhibition of the sodium-dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat models. <i>Pharmacology research &amp; perspectives</i> 10(2) e00938–None. DOI:<a href=&quot;https://doi.org/10.1002/prp2.938&quot;>10.1002/prp2.938</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35194979/&quot;>https://pubmed.ncbi.nlm.nih.gov/35194979</a></p></li><li><p> (2019). Plenvu - a low-volume PEG-based colonoscopy preparation. <i>The Medical letter on drugs and therapeutics</i> 61(1564) 11–14. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30856159/&quot;>https://pubmed.ncbi.nlm.nih.gov/30856159</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V03AG05;
